Analgesics (Pharmacies) - Qatar

  • Qatar
  • Revenue in the Analgesics market is projected to reach US$77.41m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.30%, resulting in a market volume of US$100.20m by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$28.28 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Qatar is experiencing significant growth due to changing customer preferences, emerging trends, and local special circumstances.

Customer preferences:
Customers in Qatar are increasingly seeking over-the-counter analgesics from pharmacies due to their convenience and accessibility. The demand for analgesics is driven by the need for pain relief, especially in the case of common ailments such as headaches, muscle aches, and minor injuries. Customers prefer pharmacies as they offer a wide range of analgesic products and provide professional advice on their usage. Additionally, the growing awareness about self-medication and the desire for immediate relief contribute to the popularity of analgesics in Qatar.

Trends in the market:
One of the key trends in the Analgesics (Pharmacies) market in Qatar is the increasing demand for natural and herbal analgesics. Customers are becoming more conscious about the potential side effects of conventional analgesics and are seeking alternative options that are perceived as safer and more sustainable. This trend is driven by the growing interest in holistic health and wellness, as well as the influence of social media and online platforms that promote natural remedies. As a result, pharmacies in Qatar are expanding their product offerings to include a variety of natural and herbal analgesics to cater to this demand. Another trend in the market is the rising popularity of online pharmacies. With the increasing use of smartphones and internet penetration in Qatar, customers are increasingly turning to online platforms to purchase analgesics. Online pharmacies offer the convenience of doorstep delivery and a wide range of products to choose from. This trend is further accelerated by the COVID-19 pandemic, which has led to an increased preference for contactless shopping. As a result, pharmacies in Qatar are investing in their online presence and delivery capabilities to cater to the growing demand for online analgesics.

Local special circumstances:
Qatar has a high prevalence of chronic diseases such as diabetes, cardiovascular diseases, and obesity. These conditions often result in chronic pain, which drives the demand for analgesics. Additionally, the hot climate in Qatar can lead to heat-related ailments such as dehydration and heat exhaustion, which also contribute to the need for analgesics. The local special circumstances in Qatar, therefore, create a conducive environment for the growth of the Analgesics (Pharmacies) market.

Underlying macroeconomic factors:
The growing population and increasing disposable income in Qatar are key macroeconomic factors driving the growth of the Analgesics (Pharmacies) market. As the population continues to expand, the demand for healthcare products, including analgesics, is expected to rise. Furthermore, the high per capita income in Qatar enables individuals to afford analgesics and other healthcare products. The government's focus on improving healthcare infrastructure and services also contributes to the growth of the market. In conclusion, the Analgesics (Pharmacies) market in Qatar is growing due to changing customer preferences, emerging trends such as the demand for natural and herbal analgesics, and the popularity of online pharmacies. The local special circumstances, including the high prevalence of chronic diseases and the hot climate, further drive the demand for analgesics. The underlying macroeconomic factors, such as the growing population and increasing disposable income, also contribute to the market's growth.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)